Recent Cancer Australia grant outcomes

2011

Priority-driven Collaborative Cancer Research Scheme

Butow P
University of Sydney
Evaluation of a psychological and educational intervention for fear of cancer recurrence; a cluster randomised controlled trial
Co-funded by beyondblue, National Breast Cancer Foundation and Cancer Australia

Campbell H
Children’s Medical Research Institute
Mechanism of Δ133p53 isoform oncogenicity
Co-funded by Cure Cancer Australia Foundation and Cancer Australia

Ge Y
University of Sydney
Treating deforming tumours with real-time adaptive radiotherapy
Funded by Cure Cancer Australia Foundation

Kiely B
University of Sydney
Evaluation of a web-based tool for estimating and explaining prognosis in advanced cancer
Co-funded by beyondblue and Cancer Australia

McNees K
Children’s Medical Research Institute
The role of single stranded DNA binding proteins in the Alternative Lengthening of Telomeres mechanism
Co-funded by Cure Cancer Australia Foundation and Cancer Australia

Reid G
Asbestos Diseases Research Institute
The use of RNAi to identify new therapeutic targets for malignant mesothelioma
Funded by Cancer Australia

Vardy J
University of Sydney
Ginkgo biloba preserves cognitive function in women treated with adjuvant chemotherapy for early breast cancer: a double-blind, placebo-controlled, randomised phase III trial
Co-funded by beyondblue, National Breast Cancer Foundation and Cancer Australia

2010

Priority-driven Collaborative Cancer Research Scheme

Chen Y
The Children’s Hospital at Westmead
Tumor protein D52 overexpression and DNA repair in cancer
Co-funded by Cure Cancer Australia Foundation and Cancer Australia

Davidson A
University of Sydney – Clinical Trials Centre
NITRO - A randomised, phase III trial of adding nitroglycerin to first line chemotherapy for advanced non-small cell lung cancer
Funded by Cancer Australia

Fogarty G
University of Sydney
Whole Brain Radiotherapy following local treatment of intracranial metastases of melanoma – a randomised phase III trial
Funded by Cancer Australia

Henson J
Children's Medical Research Institute
Alternative Lengthening of Telomeres (ALT) in lung cancer: analysis of effects on patient outcomes and development of a blood test
Co-funded by Cure Cancer Australia Foundation and the National Lung Cancer Program

Hilton H
Westmead Institute for Cancer Research
The impact of aberrant progesterone signalling on lineage specification during early malignant transformation
Co-funded by Cure Cancer Australia Foundation and Cancer Australia

2009

Priority-driven Collaborative Cancer Research Scheme

De Fazio A
Westmead Institute for Cancer Research
Genomic determinants of chemosensitivity in ovarian cancer
Funded by Cancer Australia

Hahn M
Kolling Institute of Medical Research
A link between p53, RNF20 and parafibromin in malignancy
Funded by Cure Cancer Australia Foundation

Horvath L
Sydney Cancer Centre
Identifying and targeting Docetaxel resistance in hormone refractory prostate cancer
Co-funded by Prostate Cancer Foundation of Australia and Cancer Australia

Huang X
University of Sydney
hOGG1 in human skin carcinogenesis
Co-funded by Cure Cancer Australia Foundation of Australia and Cancer Australia

Napier C
Children’s Medical Research Institute
Ku: a potential repressor of the ALT telomere maintenance mechanism
Funded by Cure Cancer Australia Foundation of Australia

Pickett H
Children’s Medical Research Institute
Telomere trimming: a novel mechanism for preventing unlimited cellular proliferation
Co-funded by Cure Cancer Australia Foundation of Australia and Cancer Australia

Soon P
Kolling Institute of Medical Research
The role of microRNAs in the progression of ductal carcinoma in situ to invasive breast cancer
Co-funded by Cure Cancer Australia Foundation of Australia and Cancer Australia

Trevena L
University of Sydney
Randomised trial of consumer-led familial cancer risk tool & GP triage on risk-appropriate colorectal cancer screening
Funded by Cancer Australia

2008

Priority-driven Collaborative Cancer Research Scheme

Kilbreath S
Incidence and risk factors for lymphoedema secondary to breast cancer: a prospective cohort study
Co-funded by the National Breast Cancer Foundation and Cancer Australia

Kilbreath S
Clinical correlates of lymphoedema
Funded by the National Breast Cancer Foundation

Markus A
Genome-wide analysis of pre-mRNA splicing regulation by RBM4
Co-funded by Cure Cancer Australia Foundation and Cancer Australia

Olver I
Understanding the psychosocial sequelae of surviving testicular cancer
Co-funded by beyondblue and Cancer Australia

Young J
Quality of life outcomes and cost effectiveness of pelvic exenteration for people with advanced rectal cancer
Co-funded by Cancer Council Australia and Cancer Australia

2007

Priority-driven Collaborative Cancer Research Scheme

Kilbreath S
Prevention of osteoporosis as a consequence of hormone treatment in postmenopausal women treated for breast cancer
Co-funded by Cancer Australia and the National Breast Cancer Foundation

Price T
Preop chemoradiotherapy&postop chemo with capecitabine&oxaliplatin vs. capecitabine alone in locally advanced rectal cancer
Funded by Cancer Australia